Early Life
Liu Xiucai was born in Chuzhou, Anhui Province in 1957. Information about his early life and education is limited, but he later pursued higher education, earning a Ph.D. in Biochemistry from the University of Wisconsin-Milwaukee.
Rise to Success
Liu Xiucai is the chairman of Cathay Biotech. He founded the company in Zhongguancun in 1997. Cathay Biotech went public at the Shanghai Stock Exchange in 2020. The company focuses on synthetic biology and the development and commercialization of bio-based materials, including a series of bio-based polyamides and their core monomers, bio-based long-chain diacids and bio-based pentanediamine. Liu served as CEO of Unistone Pharmaceutical Co before joining Cathay Biotech in 2019.
Key Business Strategies
Cathay Biotech's success is tied to its focus on synthetic biology and bio-based materials. The company has invested heavily in research and development, resulting in several bio-based first-kind compounds and polymers. Liu also focused on building a strong R&D platform for biological manufacturing and commercializing its technologies. In 2020, Liu led the company to go public on the Shanghai STAR stock market.
Philanthropy
Information on Liu Xiucai's specific philanthropic initiatives and amounts is limited in the search results.